• By ICR Secretariat
  • Posted Tuesday, March 16, 2021

CHMP issues positive opinion for Lilly’s COVID-19 antibodies

http://www.pharmatimes.com/news/chmp_issues_positive_opinion_for_lillys_covid-19_antibodies_1364767

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the use of Eli Lilly’s COVID-19 antibodies bamlanivimab and etesevimab.